The company criticized for hiking the price of EpiPens by more than 400% in the past decade announced measures on Thursday to reduce the price for some individuals.
Mylan pharmaceuticals will offer a discount of up to $300 for patients whose health plans require “higher out-of-pocket costs.” This could cut the costs in half for some patients, according to a press release. The company will also expand access to a program that provides epipens to uninsured patients.
“We recognize the significant burden on patients from continued, rising insurance premiums,” said Mylan CEO Heather Bresch in the release. “Patients deserve increased price transparency and affordable care.”
Politicians on both sides of the aisle have criticized the rapid price increase for the medical devices in recent weeks, including Democratic presidential candidate Hillary Clinton.
- Here's Where All The Strongest Hurricanes Have Hit the U.S. in the Past 50 Years
- 2022 Time100 NEXT: TIME’s List Of Emerging Leaders Who Are Shaping the Future
- Industrial Farming Causes Climate Change. The ‘Slow Food’ Movement Wants to Stop It
- Here Are the 12 New Books You Should Read in October
- Artist Oliver Jeffers Wants to Paint the World Out of a Corner
- A Vibrant North Korean Community in London Finds Its Days Are Numbered
- COVID-19 Vaccines Can Make Periods Longer, Study Says
- Column: What Happened When My Entire Family Came Out
